Ocrevus & COVID-19

11.5%

of users reported COVID-19

49.3%

also reported Hospitalization

69.8%

are women

Hospitalization

49.3%

Severe reaction

31.7%

Death

17.8%

Life-threatening condition

0.9%

Disability

0.2%

Ocrevus: general information

10 - 19 years

0.4%

20 - 29 years

6.3%

30 - 39 years

18.7%

40 - 49 years

26.2%

50 - 59 years

27.9%

60 - 69 years

16.8%

70 - 79 years

3.7%

80 - 89 years

0.1%